Tested Species Reactivity:HumanPredicted Species Reactivity:HumanProduct Format:Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.Clonality:PolyclonalHost:RabbitApplication:WBReconstitution and Storage:For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles.Gene Symbol:SEPT11NCBI Gene Id:55752Swissprot Id:Q9NVA2Alias Symbols:SEPT11, Replacement Item:This antibody may replace item sc-116662 from Santa Cruz Biotechnology.Description of Target:SEPT11 belongs to the conserved septin family of filament-forming cytoskeletal GTPases that are involved in a variety of cellular functions including cytokinesis and vesicle trafficking.Protein Size (# AA):429Molecular Weight:47kDaPurification:Affinity purifiedTissue Tool:Find tissues and cell lines supported by DNA array analysis to express SEPT11. RNA Seq:Find tissues and cell lines supported by RNA-seq analysis to express SEPT11. Immunogen:The immunogen is a synthetic peptide directed towards the C-terminal region of Human SEPT11Peptide Sequence:Synthetic peptide located within the following region: KKVEDKKKELEEEVNNFQKKKAAAQLLQSQAQQSGAQQTKKDKDKKNASFConcentration:Batch dependent within range: 100 ul at 0.5 - 1 mg/mlProtein Interactions:UBC; SEPT5; SEC23IP; SEPT2; CFTR; VCAM1; TMEM189; TMEM9; TMEM177; NABP2; SIN3A; FERMT2; SEPT9; TOMM40; MAD2L1BP; SEC22B; SLC9A3R2; SUCLG1; SF1; XRCC1; VDAC2; TST; TCOF1; STIM1; FSCN1; SMARCA2; OXCT1; NDUFS6; MPST; SEPT7; SH3KBP1; ELAVL1;Blocking Peptide:For anti-SEPT11 (ARP75680_P050) antibody is Catalog # AAP75680Datasheets/Manuals:Printable datasheet for anti-SEPT11 (ARP75680_P050) antibody
avivasysbio英杰华系统生物学
关键目标家族和独特内容的抗体
我们丰富的抗体目录
Aviva Systems Biology为我们的客户提供了大量用于研究和诊断应用的高质量抗体。英杰华目前提供针对7,000多种不同蛋白质靶标的抗体,这是因为我们的高通量抗体生产每月会释放200多种新抗体。Aviva的重点是针对转录,表观遗传学和细胞信号传导领域关键靶标的抗体。Aviva的抗体库包含针对许多目标的独特抗体含量,这些目标是其他地方无法买到的。我们将重点放在面向家庭的抗体生产上,从而产生了针对大多数关键蛋白质家族成员的抗体,例如转录因子,转录调节剂,RNA结合蛋白,离子通道和细胞膜靶蛋白。
不断努力研发。
英杰华(Aviva)还拥有大量额外的17,000种抗体,这些抗体目前正在使用6个组织和6个细胞系进行全面的蛋白质印迹表征和验证。随着英杰华高通量处理团队对这些候选新产品的描述,我们预计明年将发布数千种新抗体产品。
容纳客户反馈。
英杰华欢迎客户提出建议,并鼓励研究人员通过info@avivasysbio.com与我们联系,以寻求满足其研究要求的特定抗体。如果我们有满足您需求的抗体,但尚未发布,我们将齐心协力使您的目标在队列中前进,并在发布新抗体时提醒您有可用的新抗体。